Boston Scientific
(NYSE: BSX)
announced that it appointed a new SVP of investor relations and a new chief accounting officer.
In an SEC filing, the company announced the appointments, made on Jan. 26. Jonathan Monson takes over as SVP, investor relations, effective March 1, 2024. Monson currently serves as SVP, global controller and chief accounting officer, positions he took up in July 2019.
With Monson departing those roles, Boston Scientific chose Emily Woodworth as SVP, global controller and chief accounting officer. Woodworth takes over on March 1 as well. She currently serves as VP of finance and controller of the company’s Urology unit, having also taken on those posts in July 2019.
Before her current role, Woodworth was director of global technical accounting and external reporting from April 2016 until July 2019. Prior to that, she served as controller and finance director for Boston Scientific’s Cork, Ireland, manufacturing plant and neuromodulation business, respectively.